Tailor Bio

Founded 2019
Employees 10+
Primary contact
Ketton Suite, The King Centre
Main Road, Barleythorpe, Oakham
LE15 7WD Rutland
United Kingdom
Diseases & Conditions
With its AI-driven drug discovery platform, Tailor Bio is bringing precision medicine to the deadliest cancers. It provides clinical decision support to physicians, allowing them to select the best therapy for their patients' treatments. To do this, Tailor Bio's technology decodes chromosomal instability — a genomic phenomenon present in 80% of all cancers — and uses mutational signatures as biomarkers to inform therapy selection decisions.
Founded 2019
Employees 10+
Primary contact
Ketton Suite, The King Centre
Main Road, Barleythorpe, Oakham
LE15 7WD Rutland
United Kingdom
Diseases & Conditions

Funding 💰

Select investors Acequia Capital, Ascension, First In Ventures, Accelerate Cambridge, Innovate UK

Key people 🧑‍🤝‍🧑

Highlights

  • An unmet need: Many of the deadliest cancers share a common feature: extreme Chromosomal Instability (CIN). CIN manifests as an accumulation of structural and numerical chromosomal abnormalities in cancer cells. These changes result in chaotic genomes and are associated with metastasis, poor prognosis, and treatment resistance. While precision medicine approaches have improved the survival rates of many cancers, these improvements have been focussed on cancers without CIN. Cancers with extreme CIN have not seen significant improvements in overall survival. Therefore, there is an unmet need for treating cancers with extreme CIN.
  • Opportunity: Tailor Bio's technology platform unlocks new methods of drug target discovery for the development of pan-cancer precision therapies. Additionally, it enables them to stratify patients according to their treatment response to different targeted therapies and chemotherapy.
  • Great science team: Tailor Bio's team consists of scientific group leaders from the University of Cambridge, the Spanish National Cancer Institute and talented individuals committed to making a difference.

Video ▶️

Last update: April 15, 2023